Clinical Trial Update: Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating short-course radiotherapy followed by chemotherapy and a PD-1 inhibitor for locally advanced rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer
• Rectal Neoplasms

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Rectal Neoplasms Malignant, Radiotherapy | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING